WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
Research, Clinical, and Policy Implications Discontinuation is a common issue for many chronic therapies, but it’s ...
This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get ...
Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Zach Gerhart-Hines, an associate professor of metabolic research, said: 'While GLP-1-based therapies have revolutionised ...